Equities

Energenesis Biomedical Co Ltd

6657:TAI

Energenesis Biomedical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)52.00
  • Today's Change-0.10 / -0.19%
  • Shares traded42.06k
  • 1 Year change-14.05%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments699485726
Total Receivables, Net2.261.861.66
Total Inventory0.730.560.69
Prepaid expenses171612
Other current assets, total0.040.040.03
Total current assets719503740
Property, plant & equipment, net778389
Goodwill, net------
Intangibles, net263951
Long term investments------
Note receivable - long term------
Other long term assets5.595.905.32
Total assets829631886
LIABILITIES
Accounts payable0.340.370.30
Accrued expenses121112
Notes payable/short-term debt000
Current portion long-term debt/capital leases5.045.595.75
Other current liabilities, total4.027.339.24
Total current liabilities212427
Total long term debt3.243.956.19
Total debt8.289.5412
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities252833
SHAREHOLDERS EQUITY
Common stock760668664
Additional paid-in capital394200308
Retained earnings (accumulated deficit)(350)(266)(119)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity804603852
Total liabilities & shareholders' equity829631886
Total common shares outstanding766766
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.